Replies to post #14300 on Biotech Values

[io_io]

GTCB:

<<<Specifically, the investigators wanted ATryn because they think it contains less heparin contamination than plasma-derived AT.>>>

To us this was old news, except for the reasoning described above, which was discussed on the CC today ?